ENDRA Life Sciences Inc.
NDRANasdaqCIK 1681682HealthcareFiscal year ends Dec 31
Reports and events: 194 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-07-1716:16 ET | 8-K | 3.01 Delisting notice | 0001654954-24-009066 |
| 2024-06-2516:06 ET | DEF 14A | Proxy statementPeriod 2024-08-06 | 0001654954-24-008176 |
| 2024-06-0608:00 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-24-007415 |
| 2024-05-3116:21 ET | S-1/A | Registration statement, amended | 0001654954-24-007150 |
| 2024-05-2008:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-24-006635 |
| 2024-05-1416:26 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001654954-24-006243 |
| 2024-05-1416:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-24-006233 |
| 2024-05-1017:18 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-24-005981 |
| 2024-05-1017:17 ET | S-1/A | Registration statement, amended | 0001654954-24-005980 |
| 2024-05-0316:05 ET | 8-K | 3.01 Delisting notice | 0001654954-24-005552 |
| 2024-04-1917:10 ET | S-1 | Registration statement | 0001654954-24-004823 |
| 2024-03-2816:38 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001654954-24-003873 |
| 2024-03-2816:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-24-003868 |
| 2023-11-1416:07 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001654954-23-014357 |
| 2023-11-1416:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-23-014355 |
| 2023-08-1416:45 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001654954-23-010779 |
| 2023-08-1416:13 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-23-010765 |
| 2023-08-1008:01 ET | 8-K | 5.07 Shareholder vote results | 0001654954-23-010417 |
| 2023-07-2516:02 ET | 8-K | 8.01 Other events | 0001654954-23-009661 |
| 2023-07-0617:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-23-008901 |
| 2023-05-2416:03 ET | DEF 14A | Proxy statementPeriod 2023-07-06 | 0001654954-23-007157 |
| 2023-05-1516:55 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001654954-23-006594 |
| 2023-05-1516:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-23-006560 |
| 2023-05-0216:16 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-23-005633 |
| 2023-04-1921:39 ET | S-1/A | Registration statement, amended | 0001654954-23-004909 |
| 2023-04-1809:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-23-004872 |
| 2023-04-1809:06 ET | S-1/A | Registration statement, amended | 0001654954-23-004871 |
| 2023-03-3017:09 ET | S-1 | Registration statement | 0001654954-23-003937 |
| 2023-03-1616:51 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001654954-23-003044 |
| 2023-03-1416:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-23-002841 |
| 2022-12-2316:12 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001654954-22-016935 |
| 2022-12-1906:08 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001654954-22-016650 |
| 2022-12-0817:28 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001654954-22-016272 |
| 2022-12-0216:07 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001654954-22-016066 |
| 2022-11-1417:01 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001654954-22-015303 |
| 2022-11-1416:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-22-015284 |
| 2022-10-1716:15 ET | DEF 14A | Proxy statementPeriod 2022-11-29 | 0001140361-22-037399 |
| 2022-09-2716:38 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001654954-22-012997 |
| 2022-08-1517:47 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001654954-22-011398 |
| 2022-08-1517:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-22-011392 |
| 2022-06-2316:00 ET | 8-K | 5.07 Shareholder vote results | 0001654954-22-008684 |
| 2022-05-1217:01 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001654954-22-006607 |
| 2022-05-1216:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-22-006598 |
| 2022-05-0216:03 ET | DEF 14A | Proxy statementPeriod 2022-06-02 | 0001654954-22-005731 |
| 2022-04-2108:08 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-22-005229 |
| 2022-03-3017:01 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001654954-22-004172 |
| 2022-03-3016:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-22-004163 |
| 2022-02-1008:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-22-001378 |
| 2022-01-0716:31 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-22-000322 |
| 2021-11-1517:11 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001654954-21-012249 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 16:42 ET. Listed shows no prices and gives no investment advice.